Melissa Kotterman
Inversor de Capital Privado en Berkeley Frontier Fund .
Perfil
Melissa Kotterman is the founder of 4D Molecular Therapeutics, Inc. which was founded in 2013.
She held the title of Vice President-Discovery & Engineering from 2013 to 2021.
Dr. Kotterman is also the founder of Ignite Immunotherapy, Inc. Currently, she is a Venture Partner at Berkeley Frontier Fund.
Dr. Kotterman received an undergraduate degree from Carnegie Mellon University and a doctorate degree from the University of California, Berkeley in 2013.
Cargos activos de Melissa Kotterman
| Empresas | Cargo | Inicio |
|---|---|---|
Berkeley Frontier Fund
 Berkeley Frontier Fund Investment ManagersFinance Berkeley Frontier Fund (Berkeley Frontier Fund) is a venture capital firm founded in 202. The firm is headquartered in Berkeley, California. | Inversor de Capital Privado | - |
Antiguos cargos conocidos de Melissa Kotterman.
| Empresas | Cargo | Fin |
|---|---|---|
| 4D MOLECULAR THERAPEUTICS, INC. | Fundador | 01/11/2021 |
Ignite Immunotherapy, Inc.
 Ignite Immunotherapy, Inc. BiotechnologyHealth Technology Part of Pfizer Inc., Ignite Immunotherapy, Inc. is a company that designs and develops oncolytic virus vaccines. The company is based in New York, NY. The company was founded by David Schaffer, Douglas Hanahan, David H. Kirn, Theresa Janke, Melissa Kotterman. The CEO is Monika A. Vnuk. | Fundador | - |
Formación de Melissa Kotterman.
| Carnegie Mellon University | Undergraduate Degree |
| University of California, Berkeley | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| 4D MOLECULAR THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Ignite Immunotherapy, Inc.
Ignite Immunotherapy, Inc. BiotechnologyHealth Technology Part of Pfizer Inc., Ignite Immunotherapy, Inc. is a company that designs and develops oncolytic virus vaccines. The company is based in New York, NY. The company was founded by David Schaffer, Douglas Hanahan, David H. Kirn, Theresa Janke, Melissa Kotterman. The CEO is Monika A. Vnuk. | Health Technology |
Berkeley Frontier Fund
Berkeley Frontier Fund Investment ManagersFinance Berkeley Frontier Fund (Berkeley Frontier Fund) is a venture capital firm founded in 202. The firm is headquartered in Berkeley, California. | Finance |
- Bolsa de valores
- Insiders
- Melissa Kotterman
